S. Kotecha (Cardiff, United Kingdom), R. Ross-Russell (Cambridge, United Kingdom)
The role of anti-proteases in the development of chronic lung disease of prematurity (CLD)
P. L. Davies, N. C. Maxwell, O. B. Spiller, E. Remmell-O¿Donnell, S. Kotecha (Cardiff, United Kingdom; Boston, MA, United States Of America)
|   |
Exhaled nitric oxide levels and severity of bronchopulmonary dysplasia (BPD) development
C. May, O. Williams, A. Milner, G. Rafferty, S. Hannam, A. Greenough (London, United Kingdom)
| |
The role of infection in the development of chronic lung disease of prematurity
N. C. Maxwell, P. L. Davies, M. L. Beeton, E. P. McGreal, O. B. Spiller, S. Kotecha (Cardiff, United Kingdom)
| |
The relationship between ureaplasma spp. and the development of chronic lung disease of prematurity: a survey of senior neonatologists
N. C. Maxwell, D. Nuttall, O. B. Spiller, S. Kotecha (Cardiff, United Kingdom)
| |
Instituting paediatric intensive care for children with severe chronic lung disease – ethical dilemmas
R. Ross Russell (Cambridge, United Kingdom)
|  |
The assessment of pulmonary function in premature infants at school age
A. Irina, V. Anna (Yaroslavl, Russian Federation)
| |
Respiratory function in eight year old prematurely born BPD children according to hospitalisation for respiratory syncytial virus (RSV) infection in the first two years
A. Greenough, J. Alexander, J. Boorman, P. Chetcuti, W. Lenney, N. Shaw, K. Sylvester (London, Stoke on Trent, Maidenhead, Leeds, Liverpool, United Kingdom)
| |
Conclusion lecture: long term outcomes of infants with chronic lung disease
E. Vrijlandt (Groningen, Netherlands)
| |